MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹381 Cr | ₹314 Cr | ₹266 Cr | ₹185 Cr | ₹236 Cr |
What is the latest Consolidated Net Profit of MARKSANS PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹381 Cr |
| Mar2025 | ₹314 Cr |
| Mar2024 | ₹266 Cr |
| Mar2023 | ₹185 Cr |
| Mar2022 | ₹236 Cr |
How is Consolidated Net Profit of MARKSANS PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹381 Cr | 21.32 | |
| Mar2025 | ₹314 Cr | 17.80 | |
| Mar2024 | ₹266 Cr | 44.29 | |
| Mar2023 | ₹185 Cr | -21.77 | |
| Mar2022 | ₹236 Cr | - | |
Compare Consolidated Net Profit of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹14,368.7 Cr | -2.5% | -4.1% | 91.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,466.0 Cr | -0.8% | -5.1% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -3.2% | -1.4% | 53.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -1.6% | -6% | 32.1% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | 0% | -3.6% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 3.1% | 8.7% | -1.5% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -2.5% |
-4.1% |
91.1% |
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses